Weekly Poll #2: What do you see as the most viable alternative pre-revenue financing option?
This is the second of 4 weekly Polls hosted throughout July that will accompany the August edition of Drugs&Dealers Magazine ‘Lost in Translation: Tech Transfer and Start-up Capital’.
The results from this Poll will be published exclusively within the weekly Subscriber newsletter and analysed within the August issue of Drugs&Dealers. Thanks for voting.
If you are interested in learning what options are open to biotechs in pursuing alternative pre-revenue financing sources, plus how these are viewed by the investor community, you should consider attending our ‘Biotechs and the City - Tech Transfer and Start-up Capital’ evening panel and networking reception on the 4th September.